DEFA14A: AlphaVest Clarifies Shareholder Redemption Procedures

AlphaVest Acquisition Corp. issued a supplement to its proxy statement, detailing updated procedures for public shareholders to exercise redemption rights ahead of the September 19, 2025 Extraordinary General Meeting.

Summary

• AlphaVest Acquisition Corp. (AlphaVest) filed Supplement No. 2, dated September 12, 2025, to its definitive proxy statement, which was originally filed on September 2, 2025, and supplemented on September 4, 2025.
• The supplement clarifies and amends shareholder redemption rights and instructions for the Extraordinary General Meeting (EGM) scheduled for September 19, 2025, at 9:30 a.m. Eastern Time.
• To exercise redemption rights, public shareholders must (1) separate units into underlying public shares and public rights (if applicable), (2) submit a written request to the transfer agent by 5:00 p.m. Eastern Time on September 17, 2025, and (3) deliver their public shares physically or electronically via DTC's DWAC system.
• Shareholders who previously submitted shares for redemption in connection with the Business Combination Meeting (September 5, 2025) and also instruct redemption for the Extension EGM will have their shares automatically redeemed upon Merger consummation, unless they withdraw the request.
• If the EGM for the Extension is not held and the Extension is not implemented, shares submitted solely for redemption in connection with the Extension EGM will not be redeemed, and shareholders will receive shares of the combined public company (Pubco Shares).
• AlphaVest intends to complete the Merger on or before the Termination Date if conditions are satisfied or waived, in which case the EGM for the Extension is expected to be canceled.
• The company will only hold the EGM and implement the Extension if it determines it may not be able to complete the Merger by the Termination Date.
• The Trust Account held marketable securities with a fair value of approximately $18,876,141.50 as of the Record Date.
• A Public Shareholder, together with any affiliate or group, is restricted from redeeming more than an aggregate of 15% of the Public Shares without the Company's consent.

Sentiment

Score: 5

Explanation: The filing is neutral, providing procedural clarifications for shareholder redemption rights. It does not contain new positive or negative financial performance information, but rather outlines the mechanics of a critical SPAC process.

Positives

• Provides clear and detailed updated instructions for shareholders regarding the process to exercise redemption rights.
• Enhances transparency by outlining the conditions under which the Extension EGM may or may not be held, and the implications for redemption.

Negatives

• The redemption process is complex, requiring multiple steps, strict adherence to deadlines, and potential coordination with brokers.
• Shareholders face uncertainty regarding whether the Extraordinary General Meeting for the Extension will actually be held, which impacts their redemption decision.
• There is a risk that shareholders who only elect to redeem in connection with the Extension EGM may receive Pubco Shares instead of cash if the EGM is not held.
• A nominal cost is associated with the tendering process, which brokers may pass on to redeeming shareholders.

Risks

• Shareholders may be unable to obtain physical share certificates in time to meet the redemption deadline, potentially preventing them from exercising their rights.
• There is no assurance that the Extraordinary General Meeting for the Extension will be held or that the Extension will be implemented.
• If the Extension EGM is canceled, public shares submitted solely for redemption in connection with that meeting will not be redeemed, and shareholders will receive Pubco Shares.
• The market price of Ordinary Shares may be lower than the redemption price, and there may not be sufficient liquidity to sell shares in the open market.
• Public Shareholders are restricted from redeeming more than 15% of the Public Shares without the Company's consent, limiting large redemptions.
• If the Extension and a Business Combination are not consummated by the Termination Date, AlphaVest will be required to dissolve and liquidate the Trust Account, and all rights will expire worthless.

Future Outlook

AlphaVest intends to complete the Merger on or before the Termination Date if the conditions to the Merger are satisfied or waived. If the Merger is completed by this date, the Extraordinary General Meeting for the Extension is expected to be canceled, and the Extension will not be implemented. The company plans to hold the Extension EGM only if it determines it may not be able to complete the Merger by the Termination Date.

Management Comments

• "To exercise your redemption rights, you must (1) if you hold public shares through units, elect to separate your units into the underlying public shares and public rights prior to exercising your redemption rights with respect to the public shares, (2) submit a written request to the transfer agent by 5:00 p.m. Eastern Time on September 17, 2025, and (3) deliver your public shares to the transfer agent, physically or electronically."
• "If we complete the Merger on or before the Termination Date, we expect to cancel the extraordinary general meeting and not implement the Extension."
• "We intend to hold the extraordinary general meeting and implement the Extension only if we have determined as of the time of the extraordinary general meeting that we may not be able to complete the Merger on or before the Termination Date."

Industry Context

This filing is a standard procedural update for a Special Purpose Acquisition Company (SPAC) navigating the critical period leading up to either a business combination or an extension of its operational timeline. Such detailed clarifications on redemption rights are common as SPACs approach their deadlines, aiming to manage shareholder expectations and ensure compliance amidst the complexities of de-SPAC transactions and potential liquidations. The high redemption rates often seen in the SPAC market underscore the importance of clear communication regarding these processes.

Corporate Governance

Stakeholder Impact

• Shareholders: Directly impacted by the clarified redemption procedures, deadlines, and the potential for receiving Pubco Shares versus cash depending on the outcome of the Merger/Extension. Those holding units need to separate them.
• Transfer Agent: Responsible for processing redemption requests and share deliveries according to the updated instructions.
• Brokers/Banks: Need to facilitate share withdrawals for street name holders and may pass on nominal tendering fees to shareholders.

Next Steps

• Public shareholders must submit written redemption requests and deliver their shares by 5:00 p.m. Eastern Time on September 17, 2025.
• The Extraordinary General Meeting is scheduled for September 19, 2025, to vote on the Extension Amendment Proposal and Trust Agreement Amendment Proposal.
• AlphaVest will determine whether to proceed with the Merger or implement the Extension based on conditions by the Termination Date.

Key Dates

Recommendation

This filing is a procedural update clarifying shareholder redemption rights for AlphaVest Acquisition Corp. It does not introduce new financial performance data, strategic shifts, or material events that would fundamentally alter the company's valuation or prospects. The complexities and uncertainties surrounding the Merger and Extension, and the redemption process itself, are inherent to SPACs at this stage. Therefore, a 'hold' recommendation is appropriate for investors who have already made a decision based on the underlying business combination or the SPAC's initial offering, as this filing primarily provides operational details rather than fundamental news.

Keywords

SPAC, redemption rights, proxy statement, AlphaVest Acquisition Corp., Extraordinary General Meeting, Merger, Extension, shareholder vote, Trust Account